3,3',5-triiodothyroacetic acid has been researched along with Hepatitis D in 1 studies
tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.
Hepatitis D: INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donkers, JM | 1 |
| Zehnder, B | 1 |
| van Westen, GJP | 1 |
| Kwakkenbos, MJ | 1 |
| IJzerman, AP | 1 |
| Oude Elferink, RPJ | 1 |
| Beuers, U | 1 |
| Urban, S | 1 |
| van de Graaf, SFJ | 1 |
1 other study available for 3,3',5-triiodothyroacetic acid and Hepatitis D
| Article | Year |
|---|---|
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
Topics: Animals; Antiviral Agents; Dogs; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; | 2017 |